주식/증권
➡️ 중립
관련 뉴스
Fastly anticipates 2026 revenue of $744M-$748M amid $50M-$60M free cash flow outlook
11/05/2026
Cytokinetics outlines >50% new-to-brand share goal by year-end as MYQORZO expands into the U.K. this quarter
11/05/2026
BillionToOne raises 2026 revenue outlook to $460M-$470M while launching Northstar Clear on December 15
11/05/2026
Asia stocks mixed as chip rout triggers KOSPI trading halt; China outperforms
11/05/2026